enow.com Web Search

  1. Ad

    related to: pulmonary embolism guidelines accp treatment options for patients
  2. wexnermedical.osu.edu has been visited by 10K+ users in the past month

    262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464

Search results

  1. Results from the WOW.Com Content Network
  2. Thromboembolism - Wikipedia

    en.wikipedia.org/wiki/Thromboembolism

    pulmonary embolism (PE) [3] [4] [5] BB00. VTE is a common cardiovascular disorder with significant morbidity and mortality. [ 3 ] [ 4 ] [ 5 ] VTE can present with various symptoms, such as painful leg swelling, chest pain, dyspnea , hemoptysis , syncope , and even death, depending on the location and extent of the thrombus.

  3. Thrombosis prevention - Wikipedia

    en.wikipedia.org/wiki/Thrombosis_prevention

    Those who remain undiagnosed and not treated prophylactically have a 26% chance of developing a fatal embolism. Another 26% develop another embolism. Between 5% and 10% of all in hospital deaths are due to pulmonary embolism (as a consequence of thrombosis). Estimates of the incidence of pulmonary embolism in the US is 0.1% persons/year.

  4. Pulmonary embolism - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_embolism

    The pulmonary embolism rule-out criteria (PERC) helps assess people in whom pulmonary embolism is suspected, but unlikely. Unlike the Wells score and Geneva score , which are clinical prediction rules intended to risk stratify people with suspected PE, the PERC rule is designed to rule out the risk of PE in people when the physician has already ...

  5. Chronic thromboembolic pulmonary hypertension - Wikipedia

    en.wikipedia.org/wiki/Chronic_thromboembolic...

    Some patients may present with normal or near-normal pulmonary pressures at rest despite symptomatic disease. These patients are labelled as having chronic thromboembolic disease (CTED). [6] Diagnosis is made after at least three months of effective blood thinning to discern this condition from subacute pulmonary embolism.

  6. Low-molecular-weight heparin - Wikipedia

    en.wikipedia.org/wiki/Low-molecular-weight_heparin

    Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. [1] They are used in the prevention of blood clots and, in the treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism), and the treatment of myocardial infarction.

  7. Thrombolysis - Wikipedia

    en.wikipedia.org/wiki/Thrombolysis

    Thrombolysis, also called fibrinolytic therapy, is the breakdown of blood clots formed in blood vessels, using medication.It is used in ST elevation myocardial infarction, stroke, and in cases of severe venous thromboembolism (massive pulmonary embolism or extensive deep vein thrombosis).

  8. Thrombosis - Wikipedia

    en.wikipedia.org/wiki/Thrombosis

    This type of embolism is known as a thromboembolism. Complications can arise when a venous thromboembolism (commonly called a VTE) lodges in the lung as a pulmonary embolism. An arterial embolus may travel further down the affected blood vessel, where it can lodge as an embolism. [citation needed]

  9. Tissue-type plasminogen activator - Wikipedia

    en.wikipedia.org/wiki/Tissue-type_plasminogen...

    Pulmonary embolism (blood clots that have moved to the lung arteries) is usually treated with heparin generally followed by warfarin. If pulmonary embolism causes severe instability due to high pressure on the heart ("massive PE") and leads to low blood pressure, recombinant tPA is recommended. [22] [23] [24]

  1. Ad

    related to: pulmonary embolism guidelines accp treatment options for patients